Results of a multicenter, 8-week, parallel-group, randomized, double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension

Clinical Therapeutics

Volumn 27, Issue 4, 2005, Pages 441-450

  Park, Sungha ^a   Chung, Namsik ^a   Kwon, Jun ^b   Yoon, Jung Han ^c   Kim, Young Jo ^d   Han, Dae Suk ^a   Kim, Hyun Seung ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

Author keywords

Amlodipine; Besylate; Blood pressure; Calcium channel blockers; Drugs; Hypertension; Maleate; Salt

Indexed keywords

AMLODIPINE BESYLATE; AMLODIPINE MALEATE; ANTIHYPERTENSIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FACE EDEMA; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; KOREA; LEG EDEMA; MALE; PARESTHESIA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

ADULT; AGED; AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; KOREA; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 19544390886     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.04.001     Document Type: Article

References (20)

1. Karch F.E., Pordy R., Benz J.R. Mibefradil Hypertension Study Group Comparative efficacy and tolerability of two long-acting calcium channel antagonists, mibefradil and amlodipine, in essential hypertension Clin Ther 19 1997 1368 1378
2. Oparil S., and Calhoun D.A. The calcium antagonists in the 1990s. An overview Am J Hypertens 4 1991 396S 405S
3. Eisenberg M.J., Brox A., and Bestawros A.N. Calcium channel blockers: An update Am J Med 116 2004 35 43
4. Abernethy D.R. Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonist Am J Cardiol 80 1997 4C 11C
5. [published corrections appear in JAMA. 2003;289:178 and JAMA. 2004;291:2196] The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
6. Pepine C.J., Handberg-Thurmond E., and Marks R.G. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): An Internet-based randomized trial in coronary artery diseasepatients with hypertension J Am Coll Cardiol 32 1998 1228 1237
7. Opie L.H. Calcium channel antagonists in the treatment of coronary artery disease: Fundamental pharmacological properties relevant to clinical use Prog Cardiovasc Dis 38 1996 273 290
8. Frishman W.H. Current status of calcium channel blockers Curr Probl Cardiol 19 1994 637 688
9. Mehta J.L., Lopez L.M., and Vlachakis N.D. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension Am Heart J 125 1993 1704 1710
10. [published correction appears in Eur J Clin Pharmacol. 1995;48:314] Detry J.M., Block P., De Backer G., Degaute J.P. Belgian Collaborative Study Group Patient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension Eur J Clin Pharmacol 47 1995 477 481
11. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
12. Osterloh I. The safety of amlodipine Am Heart J 118 1989 1114 1120
13. Calvo C., Gude F., and Abellan J. A comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly Clin Drug Invest 19 2000 317 326
14. Lacourciere Y., Poirier L., and Lefebvre J. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension Am J Hypertens 8 1995 1154 1159
15. Neaton J.D., Grimm R.H., Prineas R.J. Treatment of Mild Hypertension Study Research Group Treatment of mild hypertension study. Final results JAMA 270 1993 713 724
16. Pedrinelli R., Dell'Omo G., and Nuti M. Heterogeneous effect of calcium antagonists on leg oedema: A comparison of amlodipine versus lercanidipine in hypertensive patients J Hypertens 21 2003 1969 1973
17. Pedrinelli R., Dell'Omo G., and Mariani M. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension J Hum Hypertens 15 2001 455 461
18. van Hamersvelt H.W., Kloke H.J., and de Jong D.J. Oedema formation with the vasodilators nifedipine and diazoxide: Direct local effect or sodium retention? J Hypertens 14 1996 1041 1045
19. Pedrinelli R., Dell'Omo G., Melillo E., and Mariani M. Amlodipine, enalapril, and dependent leg edema in essential hypertension Hypertension 35 2000 621 625
20. Lund-Johansen P., Stranden E., and Helberg S. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine J Hypertens 21 2003 1003 1010